-

CORPAY, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Corpay, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CPAY

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Corpay, Inc. (“Corpay”) (NYSE: CPAY) breached their fiduciary duties to Corpay and its shareholders.

Scott+Scott Attorneys at Law LLP, an international securities and consumer rights litigation firm, is investigating whether the directors of Corpay, Inc. (NYSE: CPAY) breached their fiduciary duties to Corpay and its shareholders.

Share

CLICK HERE TO LEARN MORE

Scott+Scott is investigating whether members of Corpay’s board of directors or senior management failed to manage Corpay in an acceptable manner, in breach of their fiduciary duties to Corpay, and whether Corpay and its shareholders have suffered damages as a result.

On January 6, 2026, the Eleventh Circuit Court of Appeals affirmed judgment in favor of the Federal Trade Commission against Corpay for engaging in deceptive advertising and unfair billing practices regarding fuel cards.

What You Can Do – CLICK HERE FOR YOUR OPTIONS AS A SHAREHOLDER

If you own shares of Corpay, you may have legal claims against Corpay’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About Us

Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations.

With 150 attorneys plus supporting staff in eight offices in the United States as well as one office in Canada and three in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief.

Our attorneys have been recognized across legal publications, including by Lawdragon for being among the 500 Top Financial Lawyers and the 500 Leading Global Antitrust & Competition Lawyers. In addition, we have received top rankings by WWL: Commercial Litigation, Legal 500 in Antitrust as well as Securities Litigation, Chambers, and Best Lawyers®. Our attorneys have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States.

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
(844) 818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NYSE:CPAY

Release Versions
$Cashtags

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
(844) 818-6982
jpettigrew@scott-scott.com

Social Media Profiles
More News From Scott+Scott Attorneys at Law LLP

CELSIUS HOLDINGS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Celsius Holdings, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CELH

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Celsius Holdings, Inc. (NASDAQ: CELH) failed to manage Celsius in an acceptable manner, breaching their fiduciary duties to Celsius, and whether Celsius and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On June 4, 2026, the Office of the Texas Attorney Genera...

ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) failed to manage ADMA Biologics in an acceptable manner, breaching their fiduciary duties to ADMA Biologics, and whether ADMA Biologics and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On March 24, 2026, Culper Research pu...

ZILLOW GROUP, INC. INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Zillow Group, Inc.’s Directors and Officers for Breach of Fiduciary Duties – Z, ZG

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Zillow Group, Inc. (NASDAQ: Z, ZG) failed to manage Zillow in an acceptable manner, breaching their fiduciary duties to Zillow, and whether Zillow and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On September 30, 2025, the Federal Trade Commission filed a laws...
Back to Newsroom